25 XP   0   0   10

Theralase Technologies Inc.
Buy, Hold or Sell?

Let's analyse Theralase together

PenkeI guess you are interested in Theralase Technologies Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Theralase Technologies Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Theralase Technologies Inc.

I send you an email if I find something interesting about Theralase Technologies Inc..

Quick analysis of Theralase (30 sec.)










What can you expect buying and holding a share of Theralase? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.01
Expected worth in 1 year
$-0.01
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-16.3%

For what price can you sell your share?

Current Price per Share
$0.12
Expected price per share
$0.12 - $0.13
How sure are you?
50%

1. Valuation of Theralase (5 min.)




Live pricePrice per Share (EOD)

$0.12

Intrinsic Value Per Share

$-0.18 - $-0.10

Total Value Per Share

$-0.17 - $-0.09

2. Growth of Theralase (5 min.)




Is Theralase growing?

Current yearPrevious yearGrowGrow %
How rich?$1.9m$3m-$1.1m-62.3%

How much money is Theralase making?

Current yearPrevious yearGrowGrow %
Making money-$3.3m-$3.8m$484.7k14.5%
Net Profit Margin-427.1%-459.8%--

How much money comes from the company's main activities?

3. Financial Health of Theralase (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#274 / 334

Most Revenue
#265 / 334

Most Profit
#205 / 334

Most Efficient
#285 / 334

What can you expect buying and holding a share of Theralase? (5 min.)

Welcome investor! Theralase's management wants to use your money to grow the business. In return you get a share of Theralase.

What can you expect buying and holding a share of Theralase?

First you should know what it really means to hold a share of Theralase. And how you can make/lose money.

Speculation

The Price per Share of Theralase is $0.1242. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Theralase.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Theralase, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.01. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Theralase.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-11.4%-0.01-11.4%-0.02-13.1%-0.02-13.6%-0.02-12.3%
Usd Book Value Change Per Share-0.01-4.1%-0.01-4.1%-0.01-6.8%0.000.6%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-4.1%-0.01-4.1%-0.01-6.8%0.000.6%0.000.1%
Usd Price Per Share0.14-0.14-0.25-0.22-0.25-
Price to Earnings Ratio-9.87--9.87--15.39--13.31--20.14-
Price-to-Total Gains Ratio-27.73--27.73--29.72--15.36--9.32-
Price to Book Ratio17.28-17.28-19.01-11.61-19.39-
Price-to-Total Gains Ratio-27.73--27.73--29.72--15.36--9.32-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1242
Number of shares8051
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (8051 shares)-40.656.21
Gains per Year (8051 shares)-162.5924.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-163-17302515
20-325-33605040
30-488-49907565
40-650-66209990
50-813-8250124115
60-976-9880149140
70-1138-11510174165
80-1301-13140199190
90-1463-14770224215
100-1626-16400248240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.011.01.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.07.00.030.0%4.08.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.012.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.07.00.030.0%4.08.00.033.3%

Fundamentals of Theralase

About Theralase Technologies Inc.

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II for the treatment of Bacillus Calmette Guérin - Unresponsive Carcinoma In-Situ non-muscle invasive bladder cancer. Further, its product candidates include TLC-2000, a superpulsed and visible red laser technology accelerates healing by reducing pain and inflammation while staying below the Maximal Permissible Exposure limit for tissue, as well as related accessories. Additionally, it provides controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100. The company has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiology Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. It sells its products to healthcare practitioners. The company was incorporated in 1989 and is based in Toronto, Canada.

Fundamental data was last updated by Penke on 2024-04-25 13:14:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Theralase Technologies Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Theralase earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Theralase to the Medical Devices industry mean.
  • A Net Profit Margin of -427.1% means that $-4.27 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Theralase Technologies Inc.:

  • The MRQ is -427.1%. The company is making a huge loss. -2
  • The TTM is -427.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-427.1%TTM-427.1%0.0%
TTM-427.1%YOY-459.8%+32.8%
TTM-427.1%5Y-564.7%+137.6%
5Y-564.7%10Y-398.9%-165.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-427.1%-12.4%-414.7%
TTM-427.1%-20.4%-406.7%
YOY-459.8%-14.8%-445.0%
5Y-564.7%-21.3%-543.4%
10Y-398.9%-25.0%-373.9%
1.1.2. Return on Assets

Shows how efficient Theralase is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Theralase to the Medical Devices industry mean.
  • -101.8% Return on Assets means that Theralase generated $-1.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Theralase Technologies Inc.:

  • The MRQ is -101.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -101.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-101.8%TTM-101.8%0.0%
TTM-101.8%YOY-91.8%-10.0%
TTM-101.8%5Y-64.7%-37.1%
5Y-64.7%10Y-68.6%+4.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-101.8%-4.1%-97.7%
TTM-101.8%-4.7%-97.1%
YOY-91.8%-4.8%-87.0%
5Y-64.7%-4.0%-60.7%
10Y-68.6%-5.2%-63.4%
1.1.3. Return on Equity

Shows how efficient Theralase is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Theralase to the Medical Devices industry mean.
  • -175.0% Return on Equity means Theralase generated $-1.75 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Theralase Technologies Inc.:

  • The MRQ is -175.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -175.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-175.0%TTM-175.0%0.0%
TTM-175.0%YOY-123.5%-51.5%
TTM-175.0%5Y-89.1%-85.9%
5Y-89.1%10Y-108.9%+19.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-175.0%-4.2%-170.8%
TTM-175.0%-5.8%-169.2%
YOY-123.5%-5.7%-117.8%
5Y-89.1%-6.3%-82.8%
10Y-108.9%-7.1%-101.8%

1.2. Operating Efficiency of Theralase Technologies Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Theralase is operating .

  • Measures how much profit Theralase makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Theralase to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Theralase Technologies Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-459.5%+459.5%
TTM-5Y-480.4%+480.4%
5Y-480.4%10Y-356.2%-124.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.3%+24.3%
TTM--16.4%+16.4%
YOY-459.5%-13.7%-445.8%
5Y-480.4%-19.9%-460.5%
10Y-356.2%-24.5%-331.7%
1.2.2. Operating Ratio

Measures how efficient Theralase is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 5.77 means that the operating costs are $5.77 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Theralase Technologies Inc.:

  • The MRQ is 5.767. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.767. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.767TTM5.7670.000
TTM5.767YOY6.043-0.276
TTM5.7675Y7.341-1.574
5Y7.34110Y5.530+1.811
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7671.442+4.325
TTM5.7671.439+4.328
YOY6.0431.431+4.612
5Y7.3411.436+5.905
10Y5.5301.374+4.156

1.3. Liquidity of Theralase Technologies Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Theralase is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.39 means the company has $1.39 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Theralase Technologies Inc.:

  • The MRQ is 1.391. The company is just able to pay all its short-term debts.
  • The TTM is 1.391. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.391TTM1.3910.000
TTM1.391YOY3.670-2.279
TTM1.3915Y6.193-4.802
5Y6.19310Y5.921+0.272
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3912.726-1.335
TTM1.3912.732-1.341
YOY3.6703.510+0.160
5Y6.1933.617+2.576
10Y5.9213.499+2.422
1.3.2. Quick Ratio

Measures if Theralase is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Theralase to the Medical Devices industry mean.
  • A Quick Ratio of 0.11 means the company can pay off $0.11 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Theralase Technologies Inc.:

  • The MRQ is 0.106. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.106. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.106TTM0.1060.000
TTM0.106YOY0.081+0.025
TTM0.1065Y0.329-0.223
5Y0.32910Y0.768-0.439
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1061.491-1.385
TTM0.1061.633-1.527
YOY0.0812.113-2.032
5Y0.3292.295-1.966
10Y0.7682.255-1.487

1.4. Solvency of Theralase Technologies Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Theralase assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Theralase to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.42 means that Theralase assets are financed with 41.9% credit (debt) and the remaining percentage (100% - 41.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Theralase Technologies Inc.:

  • The MRQ is 0.419. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.419. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.419TTM0.4190.000
TTM0.419YOY0.257+0.162
TTM0.4195Y0.202+0.216
5Y0.20210Y0.245-0.042
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4190.389+0.030
TTM0.4190.386+0.033
YOY0.2570.335-0.078
5Y0.2020.442-0.240
10Y0.2450.461-0.216
1.4.2. Debt to Equity Ratio

Measures if Theralase is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Theralase to the Medical Devices industry mean.
  • A Debt to Equity ratio of 72.0% means that company has $0.72 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Theralase Technologies Inc.:

  • The MRQ is 0.720. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.720. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.720TTM0.7200.000
TTM0.720YOY0.345+0.374
TTM0.7205Y0.290+0.430
5Y0.29010Y0.502-0.212
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7200.551+0.169
TTM0.7200.554+0.166
YOY0.3450.479-0.134
5Y0.2900.622-0.332
10Y0.5020.674-0.172

2. Market Valuation of Theralase Technologies Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Theralase generates.

  • Above 15 is considered overpriced but always compare Theralase to the Medical Devices industry mean.
  • A PE ratio of -9.87 means the investor is paying $-9.87 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Theralase Technologies Inc.:

  • The EOD is -8.757. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.871. Based on the earnings, the company is expensive. -2
  • The TTM is -9.871. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.757MRQ-9.871+1.114
MRQ-9.871TTM-9.8710.000
TTM-9.871YOY-15.389+5.519
TTM-9.8715Y-13.310+3.439
5Y-13.31010Y-20.136+6.826
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-8.757-1.077-7.680
MRQ-9.871-1.704-8.167
TTM-9.871-2.081-7.790
YOY-15.389-2.978-12.411
5Y-13.310-2.379-10.931
10Y-20.136-1.726-18.410
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Theralase Technologies Inc.:

  • The EOD is -9.738. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.977. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.977. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.738MRQ-10.977+1.239
MRQ-10.977TTM-10.9770.000
TTM-10.977YOY-15.484+4.507
TTM-10.9775Y-14.309+3.331
5Y-14.30910Y-13.923-0.385
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-9.738-0.932-8.806
MRQ-10.977-1.578-9.399
TTM-10.977-2.973-8.004
YOY-15.484-6.318-9.166
5Y-14.309-5.307-9.002
10Y-13.923-5.171-8.752
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Theralase is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 17.28 means the investor is paying $17.28 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Theralase Technologies Inc.:

  • The EOD is 15.326. Based on the equity, the company is expensive. -2
  • The MRQ is 17.276. Based on the equity, the company is expensive. -2
  • The TTM is 17.276. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.326MRQ17.276-1.950
MRQ17.276TTM17.2760.000
TTM17.276YOY19.008-1.732
TTM17.2765Y11.611+5.664
5Y11.61110Y19.388-7.777
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD15.3261.876+13.450
MRQ17.2762.372+14.904
TTM17.2762.434+14.842
YOY19.0083.217+15.791
5Y11.6113.893+7.718
10Y19.3884.245+15.143
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Theralase Technologies Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.005-0.0050%-0.008+67%0.001-755%0.000-4948%
Book Value Per Share--0.0080.0080%0.013-38%0.028-71%0.022-63%
Current Ratio--1.3911.3910%3.670-62%6.193-78%5.921-77%
Debt To Asset Ratio--0.4190.4190%0.257+63%0.202+107%0.245+71%
Debt To Equity Ratio--0.7200.7200%0.345+108%0.290+149%0.502+43%
Dividend Per Share----0%-0%-0%-0%
Eps---0.014-0.0140%-0.016+15%-0.017+19%-0.015+7%
Free Cash Flow Per Share---0.013-0.0130%-0.016+27%-0.016+22%-0.014+8%
Free Cash Flow To Equity Per Share---0.005-0.0050%-0.007+49%-0.001-86%-0.001-71%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.095--------
Intrinsic Value_10Y_min---0.178--------
Intrinsic Value_1Y_max---0.013--------
Intrinsic Value_1Y_min---0.016--------
Intrinsic Value_3Y_max---0.036--------
Intrinsic Value_3Y_min---0.051--------
Intrinsic Value_5Y_max---0.057--------
Intrinsic Value_5Y_min---0.087--------
Market Cap29202897.600-13%32917920.00032917920.0000%58782000.000-44%51436601.280-36%58930130.640-44%
Net Profit Margin---4.271-4.2710%-4.598+8%-5.647+32%-3.989-7%
Operating Margin----0%-4.5950%-4.8040%-3.5620%
Operating Ratio--5.7675.7670%6.043-5%7.341-21%5.530+4%
Pb Ratio15.326-13%17.27617.2760%19.008-9%11.611+49%19.388-11%
Pe Ratio-8.757+11%-9.871-9.8710%-15.389+56%-13.310+35%-20.136+104%
Price Per Share0.124-13%0.1400.1400%0.250-44%0.219-36%0.251-44%
Price To Free Cash Flow Ratio-9.738+11%-10.977-10.9770%-15.484+41%-14.309+30%-13.923+27%
Price To Total Gains Ratio-24.600+11%-27.729-27.7290%-29.724+7%-15.361-45%-9.320-66%
Quick Ratio--0.1060.1060%0.081+31%0.329-68%0.768-86%
Return On Assets---1.018-1.0180%-0.918-10%-0.647-36%-0.686-33%
Return On Equity---1.750-1.7500%-1.235-29%-0.891-49%-1.089-38%
Total Gains Per Share---0.005-0.0050%-0.008+67%0.001-755%0.000-4948%
Usd Book Value--1905442.0001905442.0000%3092568.000-38%6617458.800-71%5098298.733-63%
Usd Book Value Change Per Share---0.005-0.0050%-0.008+67%0.001-755%0.000-4948%
Usd Book Value Per Share--0.0080.0080%0.013-38%0.028-71%0.022-63%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.014-0.0140%-0.016+15%-0.017+19%-0.015+7%
Usd Free Cash Flow---2998707.802-2998707.8020%-3796316.736+27%-3670615.119+22%-2274485.100-24%
Usd Free Cash Flow Per Share---0.013-0.0130%-0.016+27%-0.016+22%-0.014+8%
Usd Free Cash Flow To Equity Per Share---0.005-0.0050%-0.007+49%-0.001-86%-0.001-71%
Usd Market Cap29202897.600-13%32917920.00032917920.0000%58782000.000-44%51436601.280-36%58930130.640-44%
Usd Price Per Share0.124-13%0.1400.1400%0.250-44%0.219-36%0.251-44%
Usd Profit---3334913.318-3334913.3180%-3819676.339+15%-3973357.240+19%-3577679.016+7%
Usd Revenue--780895.987780895.9870%830699.942-6%712482.125+10%1022299.096-24%
Usd Total Gains Per Share---0.005-0.0050%-0.008+67%0.001-755%0.000-4948%
 EOD+3 -5MRQTTM+0 -0YOY+18 -145Y+10 -2210Y+7 -25

3.2. Fundamental Score

Let's check the fundamental score of Theralase Technologies Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.757
Price to Book Ratio (EOD)Between0-115.326
Net Profit Margin (MRQ)Greater than0-4.271
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.106
Current Ratio (MRQ)Greater than11.391
Debt to Asset Ratio (MRQ)Less than10.419
Debt to Equity Ratio (MRQ)Less than10.720
Return on Equity (MRQ)Greater than0.15-1.750
Return on Assets (MRQ)Greater than0.05-1.018
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Theralase Technologies Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.911
Ma 20Greater thanMa 500.123
Ma 50Greater thanMa 1000.140
Ma 100Greater thanMa 2000.138
OpenGreater thanClose0.122
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets3,277
Total Liabilities1,371
Total Stockholder Equity1,905
 As reported
Total Liabilities 1,371
Total Stockholder Equity+ 1,905
Total Assets = 3,277

Assets

Total Assets3,277
Total Current Assets1,499
Long-term Assets1,778
Total Current Assets
Cash And Cash Equivalents 44
Net Receivables 114
Inventory 658
Other Current Assets 198
Total Current Assets  (as reported)1,499
Total Current Assets  (calculated)1,015
+/- 484
Long-term Assets
Property Plant Equipment 858
Long-term Assets  (as reported)1,778
Long-term Assets  (calculated)858
+/- 920

Liabilities & Shareholders' Equity

Total Current Liabilities1,077
Long-term Liabilities294
Total Stockholder Equity1,905
Total Current Liabilities
Accounts payable 682
Total Current Liabilities  (as reported)1,077
Total Current Liabilities  (calculated)682
+/- 395
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt387
Long-term Liabilities  (as reported)294
Long-term Liabilities  (calculated)387
+/- 93
Total Stockholder Equity
Total Stockholder Equity (as reported)1,905
Total Stockholder Equity (calculated)0
+/- 1,905
Other
Capital Stock46,436
Common Stock Shares Outstanding 228,461
Net Invested Capital 1,905
Net Working Capital 421
Property Plant and Equipment Gross 2,045



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
1,142
2,528
3,285
7,102
6,241
3,323
3,564
15,470
10,021
5,945
4,161
3,277
3,2774,1615,94510,02115,4703,5643,3236,2417,1023,2852,5281,142
   > Total Current Assets 
0
2,191
2,946
6,593
5,617
2,398
2,745
14,190
8,916
4,998
2,501
1,499
1,4992,5014,9988,91614,1902,7452,3985,6176,5932,9462,1910
       Cash And Cash Equivalents 
22
1,665
1,654
4,341
2,970
254
1,034
12,549
7,880
3,692
1,509
44
441,5093,6927,88012,5491,0342542,9704,3411,6541,66522
       Net Receivables 
0
293
542
1,180
1,200
1,037
790
824
485
283
55
114
114552834858247901,0371,2001,1805422930
       Other Current Assets 
27
55
495
0
0
0
56
95
98
440
70
198
198704409895560004955527
   > Long-term Assets 
0
0
0
0
624
780
820
1,280
1,105
947
1,660
1,778
1,7781,6609471,1051,2808207806240000
       Property Plant Equipment 
189
208
233
405
570
744
673
1,155
1,041
866
1,107
858
8581,1078661,0411,155673744570405233208189
       Intangible Assets 
132
105
81
73
54
36
18
7
0
0
0
0
000071836547381105132
       Other Assets 
0
22
25
30
0
144
129
119
64
81
553
0
0553816411912914403025220
> Total Liabilities 
1,207
867
441
786
550
1,277
2,566
1,615
857
875
1,068
1,371
1,3711,0688758571,6152,5661,2775507864418671,207
   > Total Current Liabilities 
1,190
859
441
786
550
1,277
2,566
1,520
821
875
681
1,077
1,0776818758211,5202,5661,2775507864418591,190
       Short-term Debt 
0
26
0
0
0
0
0
0
0
0
0
0
0000000000260
       Short Long Term Debt 
0
26
0
0
0
0
0
0
0
0
0
0
0000000000260
       Accounts payable 
689
538
249
390
312
1,089
1,020
525
408
496
328
682
6823284964085251,0201,089312390249538689
       Other Current Liabilities 
397
294
192
1
1
1
1,201
0
765
0
595
0
0595076501,201111192294397
   > Long-term Liabilities 
0
0
0
0
0
0
0
94
36
0
387
294
294387036940000000
       Capital Lease Obligations Min Short Term Debt
0
-26
0
0
0
0
0
145
92
36
474
387
387474369214500000-260
> Total Stockholder Equity
0
1,661
2,844
6,316
5,691
2,046
999
13,855
9,164
5,070
3,093
1,905
1,9053,0935,0709,16413,8559992,0465,6916,3162,8441,6610
   Retained Earnings -63,240-58,452-53,092-48,506-42,652-35,238-31,881-25,788-20,867-13,474-12,3040
   Accumulated Other Comprehensive Income 000000000000
   Capital Surplus 000000000000
   Treasury Stock000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,070
Cost of Revenue-508
Gross Profit562562
 
Operating Income (+$)
Gross Profit562
Operating Expense-5,665
Operating Income-4,594-5,102
 
Operating Expense (+$)
Research Development2,982
Selling General Administrative2,127
Selling And Marketing Expenses-
Operating Expense5,6655,109
 
Net Interest Income (+$)
Interest Income50
Interest Expense-30
Other Finance Cost-0
Net Interest Income19
 
Pretax Income (+$)
Operating Income-4,594
Net Interest Income19
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-4,571-4,598
EBIT - interestExpense = -30
-4,571
-4,540
Interest Expense30
Earnings Before Interest and Taxes (EBIT)--4,540
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-4,571
Tax Provision--
Net Income From Continuing Ops-4,571-4,571
Net Income-4,571
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net4-19
 

Technical Analysis of Theralase
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Theralase. The general trend of Theralase is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Theralase's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Theralase Technologies Inc..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.13 < 0.13 < 0.13.

The bearish price targets are: 0.12 > 0.12 > 0.12.

Tweet this
Theralase Technologies Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Theralase Technologies Inc.. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Theralase Technologies Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Theralase Technologies Inc.. The current macd is -0.00422485.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Theralase price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Theralase. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Theralase price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Theralase Technologies Inc. Daily Moving Average Convergence/Divergence (MACD) ChartTheralase Technologies Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Theralase Technologies Inc.. The current adx is 20.62.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Theralase shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Theralase Technologies Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Theralase Technologies Inc.. The current sar is 0.11155264.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Theralase Technologies Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Theralase Technologies Inc.. The current rsi is 45.91. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Theralase Technologies Inc. Daily Relative Strength Index (RSI) ChartTheralase Technologies Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Theralase Technologies Inc.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Theralase price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Theralase Technologies Inc. Daily Stochastic Oscillator ChartTheralase Technologies Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Theralase Technologies Inc.. The current cci is -26.81853482.

Theralase Technologies Inc. Daily Commodity Channel Index (CCI) ChartTheralase Technologies Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Theralase Technologies Inc.. The current cmo is -3.13517202.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Theralase Technologies Inc. Daily Chande Momentum Oscillator (CMO) ChartTheralase Technologies Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Theralase Technologies Inc.. The current willr is -73.14814815.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Theralase is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Theralase Technologies Inc. Daily Williams %R ChartTheralase Technologies Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Theralase Technologies Inc..

Theralase Technologies Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Theralase Technologies Inc.. The current atr is 0.00686119.

Theralase Technologies Inc. Daily Average True Range (ATR) ChartTheralase Technologies Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Theralase Technologies Inc.. The current obv is 369,478.

Theralase Technologies Inc. Daily On-Balance Volume (OBV) ChartTheralase Technologies Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Theralase Technologies Inc.. The current mfi is 63.02.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Theralase Technologies Inc. Daily Money Flow Index (MFI) ChartTheralase Technologies Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Theralase Technologies Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Theralase Technologies Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Theralase Technologies Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.911
Ma 20Greater thanMa 500.123
Ma 50Greater thanMa 1000.140
Ma 100Greater thanMa 2000.138
OpenGreater thanClose0.122
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Theralase with someone you think should read this too:
  • Are you bullish or bearish on Theralase? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Theralase? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Theralase Technologies Inc.

I send you an email if I find something interesting about Theralase Technologies Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Theralase Technologies Inc..

Receive notifications about Theralase Technologies Inc. in your mailbox!